Frequency and timing of multiple skin cancer development in five cohorts
- PMID: 39929309
- PMCID: PMC12101941
- DOI: 10.1016/j.jaad.2024.12.047
Frequency and timing of multiple skin cancer development in five cohorts
Abstract
Background: Many patients will develop more than one skin cancer; however, most research to date has examined only case status.
Objective: Describe the frequency and timing of the treatment of multiple skin cancers in individual patients over time.
Methods: We conducted a longitudinal claims and electronic health record-based cohort study to examine the frequency of skin cancer multiplicity. We used a validated phenotype for counting individual skin cancers.
Results: Our combined cohort included 5,508,374 patients and 13,102,123 total skin cancers treated. Forty-three percent of patients treated for skin cancer were treated for more than one skin cancer, most within 2 years of the initial skin cancer. A subset of 3% of patients were treated for 10 or more skin cancers and contributed 22% of all skin cancers treated in the combined cohort.
Limitations: High-quality data on skin cancer types were not available. Databases and health records are not designed to capture skin cancer multiplicity well.
Conclusions: Nearly half of patients treated for skin cancer will develop at least one more. Better data formatting will allow for improved granularity in identifying individuals at high risk for multiple skin cancers and those unlikely to benefit from continued annual surveillance.
Keywords: cohort study; epidemiology; skin cancer.
Published by Elsevier Inc.
Conflict of interest statement
Conflicts of interest None disclosed.
Update of
-
Toward personalized skin cancer care: multiple skin cancer development in five cohorts.medRxiv [Preprint]. 2024 May 7:2024.05.06.24306947. doi: 10.1101/2024.05.06.24306947. medRxiv. 2024. Update in: J Am Acad Dermatol. 2025 Jun;92(6):1295-1302. doi: 10.1016/j.jaad.2024.12.047. PMID: 38766175 Free PMC article. Updated. Preprint.
References
-
- Rogers HW, Weinstock MA, Feldman SR & Coldiron BM Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012. JAMA Dermatol. 151, 1081–1086 (2015). - PubMed
-
- Wehner MR Underestimation of Cutaneous Squamous Cell Carcinoma Incidence, Even in Cancer Registries. JAMA dermatology vol. 156 1290–1291 (2020). - PubMed
-
- Marcil I & Stern RS Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis. Arch. Dermatol. 136, 1524–1530 (2000). - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
